Cargando…

Adherence to Medical Cannabis Among Licensed Patients in Israel

Objectives: To evaluate adherence among Israeli patients who are licensed to use medical cannabis and to identify factors associated with adherence to medical cannabis. Methods: Ninety-five novice licensed patients were interviewed for this cross-sectional study. The questionnaire measured demograph...

Descripción completa

Detalles Bibliográficos
Autores principales: Zolotov, Yuval, Baruch, Yehuda, Reuveni, Haim, Magnezi, Racheli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576595/
https://www.ncbi.nlm.nih.gov/pubmed/28861475
http://dx.doi.org/10.1089/can.2015.0003
_version_ 1783260211232899072
author Zolotov, Yuval
Baruch, Yehuda
Reuveni, Haim
Magnezi, Racheli
author_facet Zolotov, Yuval
Baruch, Yehuda
Reuveni, Haim
Magnezi, Racheli
author_sort Zolotov, Yuval
collection PubMed
description Objectives: To evaluate adherence among Israeli patients who are licensed to use medical cannabis and to identify factors associated with adherence to medical cannabis. Methods: Ninety-five novice licensed patients were interviewed for this cross-sectional study. The questionnaire measured demographics, the perceived patient–physician relationship, and the level of patients' active involvement in their healthcare. In addition, patients were queried about adverse effect(s) and about their overall satisfaction from this medical treatment. Results: Eighty percent (n=76) has been identified as adherent to medical cannabis use. Variables found associated with adherence were “country of origin” (immigrant status), “type of illness” (cancer vs. non-cancer), and “experiencing adverse effect(s).” Three predictors of adherence were found significant in a logistic regression model: “type of illness” (odds ratio [OR] 0.101), patient–physician relationship (OR 1.406), and level of patient activation (OR 1.132). 71.5% rated themselves being “completely satisfied” or “satisfied” from medical cannabis use. Conclusions: Our findings show a relatively high adherence rate for medical cannabis, as well as relative safety and high satisfaction among licensed patients. Additionally indicated is the need to develop and implement standardized education about this evolving field—to both patients and physicians.
format Online
Article
Text
id pubmed-5576595
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-55765952017-08-31 Adherence to Medical Cannabis Among Licensed Patients in Israel Zolotov, Yuval Baruch, Yehuda Reuveni, Haim Magnezi, Racheli Cannabis Cannabinoid Res Original Research Objectives: To evaluate adherence among Israeli patients who are licensed to use medical cannabis and to identify factors associated with adherence to medical cannabis. Methods: Ninety-five novice licensed patients were interviewed for this cross-sectional study. The questionnaire measured demographics, the perceived patient–physician relationship, and the level of patients' active involvement in their healthcare. In addition, patients were queried about adverse effect(s) and about their overall satisfaction from this medical treatment. Results: Eighty percent (n=76) has been identified as adherent to medical cannabis use. Variables found associated with adherence were “country of origin” (immigrant status), “type of illness” (cancer vs. non-cancer), and “experiencing adverse effect(s).” Three predictors of adherence were found significant in a logistic regression model: “type of illness” (odds ratio [OR] 0.101), patient–physician relationship (OR 1.406), and level of patient activation (OR 1.132). 71.5% rated themselves being “completely satisfied” or “satisfied” from medical cannabis use. Conclusions: Our findings show a relatively high adherence rate for medical cannabis, as well as relative safety and high satisfaction among licensed patients. Additionally indicated is the need to develop and implement standardized education about this evolving field—to both patients and physicians. Mary Ann Liebert, Inc. 2016-01-01 /pmc/articles/PMC5576595/ /pubmed/28861475 http://dx.doi.org/10.1089/can.2015.0003 Text en © Yuval Zolotov et al. 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Research
Zolotov, Yuval
Baruch, Yehuda
Reuveni, Haim
Magnezi, Racheli
Adherence to Medical Cannabis Among Licensed Patients in Israel
title Adherence to Medical Cannabis Among Licensed Patients in Israel
title_full Adherence to Medical Cannabis Among Licensed Patients in Israel
title_fullStr Adherence to Medical Cannabis Among Licensed Patients in Israel
title_full_unstemmed Adherence to Medical Cannabis Among Licensed Patients in Israel
title_short Adherence to Medical Cannabis Among Licensed Patients in Israel
title_sort adherence to medical cannabis among licensed patients in israel
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576595/
https://www.ncbi.nlm.nih.gov/pubmed/28861475
http://dx.doi.org/10.1089/can.2015.0003
work_keys_str_mv AT zolotovyuval adherencetomedicalcannabisamonglicensedpatientsinisrael
AT baruchyehuda adherencetomedicalcannabisamonglicensedpatientsinisrael
AT reuvenihaim adherencetomedicalcannabisamonglicensedpatientsinisrael
AT magneziracheli adherencetomedicalcannabisamonglicensedpatientsinisrael